Influence of zinc administered by total parenteral nutrition on plasmatic zinc levels, on reactive C protein, on serum interleukin-6 and on serum interleukin-6 soluble receptor, in critical patients
Objectives: To study the interrelationship between serum Interleukin-6 (IL-6), serum Interleukin-6 soluble Receptor (IL-6 sR), C-Reactive Protein (C-RP), plasmatic Zinc levels (PlZn) and their response in relation to Zn administered by TPN, in critical patients. Methods: 17 patients, receiving TPN a...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Español |
| Publicado: |
2009
|
| Acceso en línea: | Registro en Scopus Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 10852caa a22011657a 4500 | ||
|---|---|---|---|
| 001 | PAPER-8574 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518203822.0 | ||
| 008 | 140217s2009 xx ||||fo|||| 00| 0 spa|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-68149168225 | |
| 024 | 7 | |2 pubmed |a 19721908 | |
| 024 | 7 | |2 cas |a C reactive protein, 9007-41-4; zinc, 7440-66-6; C-Reactive Protein, 9007-41-4; Interleukin-6; Receptors, Interleukin-6; Zinc, 7440-66-6 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a NUHOE | ||
| 100 | 1 | |a Menéndez, A.Ma. | |
| 245 | 1 | 0 | |a Influence of zinc administered by total parenteral nutrition on plasmatic zinc levels, on reactive C protein, on serum interleukin-6 and on serum interleukin-6 soluble receptor, in critical patients |
| 260 | |c 2009 | ||
| 270 | 1 | 0 | |m De Portela, Ma. L. P. M.; Cátedra de Nutrición, Facultad de Farmacia Y Bioquímica, UBA, Junin 956, 2 p., 1113 Buenos Aires, Argentina; email: mportela@ffyb.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Greene, H.L., Hambidge, K.M., Schanler, R., Tsang, R.C., Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: Report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition (1988) American Journal of Clinical Nutrition, 48 (5), pp. 1324-1342 | ||
| 504 | |a Forbes, G., Micronutrient status in Patients Receiving Home Parenteral Nutrition (1997) Nutrition, pp. 11-12. , y cols | ||
| 504 | |a Braunschweig, C.A., Trace elements and the acute Phase response: Implications for Nutrition Support (1996) Postgraduate Course, pp. 9-20. , Washington DC, USA: Ed. American Society for Parenteral and Enteral Nutrition | ||
| 504 | |a Shenkin, A., Allwood, M.C., Oligoelementos y vitaminas en la nutrición intravenosa en adultos (2002) Nutrición Clínica, pp. 65-86. , Capítulo 4. Rombeau JL, Rollandelli RH (eds.). Nutrición Clínica Nutrición Parenteral. México DF: McGraw-Hill Interamericana; | ||
| 504 | |a Guidelines for essencial trace element preparations for parenteral use: A statement by an expert panel (1979) JAMA, 241 (19), pp. 2051-2054. , American Medical Association, Departament of Foods and Nutrition -1979b- | ||
| 504 | |a Fleming, C.R., Trace element metabolism in adult patients requiring total parenteral nutrition (1989) American Journal of Clinical Nutrition, 49 (3), pp. 573-579 | ||
| 504 | |a Prelack, K., Sheridan, R.L., Micronutrient supplementation in the critically III patient: Strategies for clinical practice (2001) Journal of Trauma - Injury, Infection and Critical Care, 51 (3), pp. 601-620 | ||
| 504 | |a Solomons, N.W., Zinc, Trace Elementos (1991) Clinincal Guide to Parenteral Micronutrition, pp. 216-231. , Thomas G Baumgartner (ed.). Chapter 9. Second Edition. USA: Lyphomed | ||
| 504 | |a King, J.C., Keen, C.L., Zinc (1994) Modern Nutrition in Health and Disease, pp. 214-230. , Chapter 10. Shils ME et al. Eighth Edition. Malvern, PA, USA: Lea & Febiger; | ||
| 504 | |a Leung, F.Y., Trace Element in Parenteral Nutrition Clinical Biochemistry, 28 (6), pp. 562-566. , 199 | ||
| 504 | |a Henzel, J.H., De Weese, M.S., Pories, M.W., Significance of mangnesium and Zinc metabolism in the surgical patients (1967) Arch Surg, 9, pp. 991-999 | ||
| 504 | |a Brocks, A., Reid, H., Glazer, G., Acute intravenous Zinc poisoning (1977) Br Med J, 1, pp. 1390-1391 | ||
| 504 | |a Pluhator-Murton, M.M., Fedorak, R.N., Audette, R.J., Marriage, B.J., Yatscoff, R.W., Gramlich, L.M., Trace element contamination of total parenteral nutrition. 1. Contribution of component solutions (1999) Journal of Parenteral and Enteral Nutrition, 23 (4), pp. 222-227 | ||
| 504 | |a Menendez, A.M., Weisstaub, A.R., Montemerlo, H., Rusi, F., Guidoni, Ma.E., Pineiro, A., Pita Martin De Portela, M.L., Zinc and copper content in individual components used to prepare pediatric total nutrition mixtures (2007) Nutricion Hospitalaria, 22 (5), pp. 545-551. , http://www.nutricionhospitalaria.com/mostrarfile.asp?ID=3948 | ||
| 504 | |a García Lorenzo Y Mateos, A., López Martínez, J., Sánchez Castilla, M., Respuesta inflamatoria sistémica: Definiciones, marcadores inflamatorios y posibilidades terapéuticas (2000) Medicina Intensiva, 24 (8), pp. 361-370 | ||
| 504 | |a Rink, L., Kirchner, H., Zinc-altered immune function and cytokine production (2000) Journal of Nutrition, 130 (5 SUPPL.), pp. 1407S-1411S | ||
| 504 | |a Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients (2002) JPEN, (25), pp. 31SA. , ASPEN Board | ||
| 504 | |a (1971) Analytical Method for Atomic Absorption Spectrophotometry, , Perkin Elmer Corp. Perkin Elmer Corp. Norwalk C.T | ||
| 504 | |a Dawson-Saunders, Trapp, R., (1994) Bioestadística Médica. 1°.ed., , Editorial El Manual Moderno; México DF | ||
| 504 | |a Weisstaub, A.R., Menéndez, A.M., Montemerlo, H., Pastene, H., Piñeiro, A., Guidoni, M.E., De Pita Martín Portela, M.L., Zinc plasmático, cobre sérico y zinc y cobre eritrocitarios en adultos sanos de Buenos Aires (2008) Acta Bioquímica Clínica, 42 (3). , En prensa | ||
| 504 | |a Cousins, R., Hempe, J.M., Cinc (1990) Present Knowledge in Nutrition, 6th Ed., pp. 289-308. , Chap. 28. M.L.Brown. Washington, D.C., USA: Ed. Nutrition Foundation | ||
| 504 | |a Menendez, A.M., Weisstaub, A., Montemerlo, H., Alloatti, S., Guidoni, M.E., Rusi, F., De Portela, M.L.P.M., Relationship between the amount of copper and zinc given to critically ill patients on total parenteral nutrition and plasma and erythrocyte copper and zinc levels (2008) Nutricion Hospitalaria, 23 (4), pp. 373-382. , http://www.nutricionhospitalaria.com/mostrarfile.asp?ID=4052 | ||
| 504 | |a Leser, H.G., Gross, V., Scheibenbogen, A., Heinisch, A., Salm, R., Lausen, K., Rückauer, R., Schölmerich, J., Elevation of serum interleukin-6 concentration preceds acute-phase response and reflects severity in acute pancreatitis (1991) Gastroenterology, (101), pp. 782-785 | ||
| 504 | |a Kishimoto, T., Interleukin-6: Discovery of pleiotropic cytokine (2006) Arthritis Research Therapy, 8 (SUPPL. 2), pp. 1-6 | ||
| 504 | |a Braunschweig, C.L., Sowers, M., Kovacevich, D.S., Hill, G.M., August, D.A., Parenteral zinc supplementation in adult humans during the acute phase response increases the febrile response (1997) Journal of Nutrition, 127 (1), pp. 70-74 | ||
| 520 | 3 | |a Objectives: To study the interrelationship between serum Interleukin-6 (IL-6), serum Interleukin-6 soluble Receptor (IL-6 sR), C-Reactive Protein (C-RP), plasmatic Zinc levels (PlZn) and their response in relation to Zn administered by TPN, in critical patients. Methods: 17 patients, receiving TPN as a consequence of acute pancreatitis (n = 4) or after a major abdominal surgery due to intestinal cancer (n = 7), intestinal fístula (n = 3), intestinal obstruction (n = 2) or intestinal íleus (n = 1) were studied. At the beginning (To) and at the end of the TPN administration (6-21days) serum IL-6 and IL-6 sR were determined by ELISA; C-RP ultrasensitive (C-RP us) by inmunoturbidimetric method; Zn was determined in TPN and in plasma by Atomic Absorption Spectrometry. Characteristics of the patients were (mean ± SD and ranges): age: 60.6 ± 11.7 (37-77) years; BMI (kg/m2): 26.0 ± 3.4 (19.9-34.0). Results: The results (mean ± standard deviation and ranges) were: Zn provided by TPN (mg/d): 6.1 ± 2.0 (range 2.8 to 10.8). Biochemical levels were, at To and Tf, respectively: (mean±SD and ranges) were at To y Tf, respectively: Zn Pl (?g/dl): 104 ± 46 (35-177); 120 ± 55 (52-229); IL-6 (pg/mL) 93 ± 74 (10-262); 117 ± 180 (7-761); IL6sR (pg/mL): 1,012 ± 322 (589-1855); 1,269 ± 451 (631-2195); C-RP us (mg/L): 71 ± 63 (2-196); 65 ± 43 (0-137). There was no correlation between variations of IL6, IL6sR, C-RP, PlZn levels and the daily amount of Zn administered in the TPN mixtures. Two patients presented a bad evolution; they received 4.2 and 5.2 md/d of Zn and showed an increase of IL6 levels, maintained high levels of IL6sR but C-RP levels decreased Conclusions: the range of 2.8 to 10.8 mg/d of Zn administered in TPN mixtures did not exacerbate the inflammatory response. |l eng | |
| 593 | |a Cátedra de Nutrición, Facultad de Farmacia Y Bioquímica, UBA, Junin 956, 2 p., 1113 Buenos Aires, Argentina | ||
| 593 | |a Instituto Argentino de Educación e Investigación en Nutrición, Buenos Aires, Argentina | ||
| 593 | |a Cátedra de Farmacia Hospitalaria Y Clínica, Facultad de Ciencias Exactas Y Naturales, Universidad de Belgrano, Buenos Aires, Argentina | ||
| 593 | |a CONICET (Consejo Nacional de Investigaciones Científicas Y Técnicas), Argentina | ||
| 690 | 1 | 0 | |a CRITICALLY ILL PATIENTS WITH PARENTERAL NUTRITION |
| 690 | 1 | 0 | |a INTERLEUKIN-6 |
| 690 | 1 | 0 | |a SOLUBLE RECEPTOR OF INTERLEUKIN-6, AND C REACTIVE PROTEIN |
| 690 | 1 | 0 | |a ZINC |
| 690 | 1 | 0 | |a C REACTIVE PROTEIN |
| 690 | 1 | 0 | |a INTERLEUKIN 6 |
| 690 | 1 | 0 | |a INTERLEUKIN 6 RECEPTOR |
| 690 | 1 | 0 | |a ZINC |
| 690 | 1 | 0 | |a ABDOMINAL SURGERY |
| 690 | 1 | 0 | |a ACUTE PANCREATITIS |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a AGED |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CLINICAL ARTICLE |
| 690 | 1 | 0 | |a CRITICALLY ILL PATIENT |
| 690 | 1 | 0 | |a DIET SUPPLEMENTATION |
| 690 | 1 | 0 | |a ENZYME LINKED IMMUNOSORBENT ASSAY |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a ILEUS |
| 690 | 1 | 0 | |a INFLAMMATION |
| 690 | 1 | 0 | |a INTESTINE CANCER |
| 690 | 1 | 0 | |a INTESTINE FISTULA |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a TOTAL PARENTERAL NUTRITION |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a AGED |
| 690 | 1 | 0 | |a C-REACTIVE PROTEIN |
| 690 | 1 | 0 | |a CRITICAL ILLNESS |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a INTERLEUKIN-6 |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a MIDDLE AGED |
| 690 | 1 | 0 | |a PARENTERAL NUTRITION, TOTAL |
| 690 | 1 | 0 | |a RECEPTORS, INTERLEUKIN-6 |
| 690 | 1 | 0 | |a ZINC |
| 690 | 1 | 0 | |a FISTULA |
| 700 | 1 | |a De Portela, Ma.L.P.M. | |
| 700 | 1 | |a Weisstaub, A. | |
| 700 | 1 | |a Montemerlo, H. | |
| 700 | 1 | |a Guidoni, Ma.E. | |
| 700 | 1 | |a Rusí, F. | |
| 700 | 1 | |a Zeni, S. | |
| 773 | 0 | |d 2009 |g v. 24 |h pp. 340-346 |k n. 3 |p Nutr. Hosp. |x 02121611 |t Nutricion Hospitalaria | |
| 856 | 4 | 1 | |u http://www.scopus.com/inward/record.url?eid=2-s2.0-68149168225&partnerID=40&md5=422c598e9f1415a66860d8f7bb30cd0e |y Registro en Scopus |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_02121611_v24_n3_p340_Menendez |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02121611_v24_n3_p340_Menendez |y Registro en la Biblioteca Digital |
| 961 | |a paper_02121611_v24_n3_p340_Menendez |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 69527 | ||